Jin Kai, Ye Juan
Department of Ophthalmology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Adv Ophthalmol Pract Res. 2022 Aug 24;2(3):100078. doi: 10.1016/j.aopr.2022.100078. eCollection 2022 Nov-Dec.
The ophthalmology field was among the first to adopt artificial intelligence (AI) in medicine. The availability of digitized ocular images and substantial data have made deep learning (DL) a popular topic.
At the moment, AI in ophthalmology is mostly used to improve disease diagnosis and assist decision-making aiming at ophthalmic diseases like diabetic retinopathy (DR), glaucoma, age-related macular degeneration (AMD), cataract and other anterior segment diseases. However, most of the AI systems developed to date are still in the experimental stages, with only a few having achieved clinical applications. There are a number of reasons for this phenomenon, including security, privacy, poor pervasiveness, trust and explainability concerns.
This review summarizes AI applications in ophthalmology, highlighting significant clinical considerations for adopting AI techniques and discussing the potential challenges and future directions.
眼科领域是医学中最早采用人工智能（AI）的领域之一。数字化眼部图像的可用性和大量数据使深度学习（DL）成为一个热门话题。
目前，眼科中的人工智能主要用于改善疾病诊断并协助针对糖尿病性视网膜病变（DR）、青光眼、年龄相关性黄斑变性（AMD）、白内障和其他眼前段疾病等眼科疾病进行决策。然而，迄今为止开发的大多数人工智能系统仍处于实验阶段，只有少数已实现临床应用。出现这种现象有多种原因，包括安全性、隐私性、普及性差、信任和可解释性问题。
本综述总结了人工智能在眼科中的应用，强调了采用人工智能技术的重要临床考虑因素，并讨论了潜在挑战和未来方向。
